A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
Clinical trial NCT03330691 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03330691
- Sponsor
- Seattle Children's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-03
- Primary completion
- 2023-09-13
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.